ZIEXTENZO
ZIEXTENZO
Approved
DIN Number
02497395
Drug Class
Human
Market Date
May 15, 2020
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02497395
AIG Number0149962001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AA13 PEGFILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PEGFILGRASTIMActive
Strength: 6 MG / 0.6 ML
Monograph: PEGFILGRASTIM